Skip to main content
Premium Trial:

Request an Annual Quote

PathoGenetix Picks Sagentia to Develop Commercial-Scale Microbial Detection System

NEW YORK (GenomeWeb News) – Sagentia said today that it has been picked by PathoGenetix to develop a commercial scale system for rapid microbial detection and strain typing based on the Woburn, Mass.-based firm's Genome Sequence Scanning technology.

PathoGenetix plans to launch the system's first commercial application, for the research market, in late 2012.

In turning the current laboratory prototype of the GSS technology into a "technically and commercially successful platform," Sagentia said it will continue integrating state-of-the-art optics and microfluidics, making the technology more robust, improving its usability, reducing costs, and increasing manufacturing efficiency.

The GSS technology was developed with more than $50 million from the US Departments of Defense and Homeland Security and combines automated sample preparation and single molecule detection to detect and characterize microbes from complex biological samples in as little as three hours.

In November PathoGenetix said it had raised $7.5 million on top of $4 million raised in August to develop and commercialize the technology.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.